TOWA Pharmaceutical Co (TSE:4553) Change In Receivables : 円-565 Mil (TTM As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is TOWA Pharmaceutical Co Change In Receivables?

TOWA Pharmaceutical Co's change in receivables for the quarter that ended in Mar. 2025 was 円6,809 Mil. It means TOWA Pharmaceutical Co's Accounts Receivable declined by 円6,809 Mil from Dec. 2024 to Mar. 2025 .

TOWA Pharmaceutical Co's change in receivables for the fiscal year that ended in Mar. 2025 was 円-565 Mil. It means TOWA Pharmaceutical Co's Accounts Receivable increased by 円565 Mil from Mar. 2024 to Mar. 2025 .

TOWA Pharmaceutical Co's Accounts Receivable for the quarter that ended in Mar. 2025 was 円61,449 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. TOWA Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 85.14.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. TOWA Pharmaceutical Co's liquidation value for the three months ended in Mar. 2025 was 円-153,498 Mil.

TOWA Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for TOWA Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOWA Pharmaceutical Co Change In Receivables Chart

TOWA Pharmaceutical Co Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Change In Receivables

Get a 7-Day Free Trial

-4,544.00

441.00

-1,592.00

-15,523.00

-565.00

TOWA Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-	525.00	7,743.00	-15,642.00	6,809.00

TOWA Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-565 Mil.

TOWA Pharmaceutical Co (TSE:4553) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

TOWA Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	61449	/	65857	*	91
=	85.14

2. In Ben Graham's calculation of liquidation value, TOWA Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

TOWA Pharmaceutical Co's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	45471	-	299199	+	0.75 * 61449	+	0.5 * 108287
=	-153,498

TOWA Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

TOWA Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TOWA Pharmaceutical Co Ltd (TSE:4553) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

TWAPF:USA 6QC:Germany

Address

2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580

Website

http://www.towayakuhin.co.jp

TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

TOWA Pharmaceutical Co Headlines

No Headlines